166 related articles for article (PubMed ID: 2449395)
1. Oral contraceptive absorption and sex hormone binding globulins in obese women: effects of jejunoileal bypass.
Victor A; Odlind V; Kral JG
Gastroenterol Clin North Am; 1987 Sep; 16(3):483-91. PubMed ID: 2449395
[TBL] [Abstract][Full Text] [Related]
2. Plasma cholecystokinin in obese patients before and after jejunoileal bypass with 3:1 or 1:3 jejunoileal ratio--no role in the increased risk of gallstone formation.
Sørensen TI; Toftdahl DB; Højgaard L; Cantor P; Klein HC; Andersen B
Dan Med Bull; 1994 Sep; 41(4):469-72. PubMed ID: 7813254
[TBL] [Abstract][Full Text] [Related]
3. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of gestagens: some problems.
Fotherby K
Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):323-8. PubMed ID: 2115297
[TBL] [Abstract][Full Text] [Related]
5. The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1.
Pakarinen P; Lähteenmäki P; Rutanen EM
Acta Obstet Gynecol Scand; 1999 May; 78(5):423-8. PubMed ID: 10326889
[TBL] [Abstract][Full Text] [Related]
6. [Preclinical research and development of norethisterone].
Mcguire JL; Hahn DW; Philipps A
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
[TBL] [Abstract][Full Text] [Related]
7. SHBG, testosterone, androstenedione, 17-OH-Progesterone plasma levels in PCO affected women treated with a triphasic oral contraceptive.
Negri P; Agnello G; Borghesani F; Tomain L; Minisci N; D'Errico G; Cavallini AR
Acta Eur Fertil; 1987; 18(6):375-80. PubMed ID: 3454501
[TBL] [Abstract][Full Text] [Related]
8. Binding of the gestagens norethisterone and levonorgestrel in blood of various species.
Jenkins N; Fotherby K
J Steroid Biochem; 1981 Oct; 14(10):1055-62. PubMed ID: 6795390
[TBL] [Abstract][Full Text] [Related]
9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
10. [Long-term effects of low-dose combined norethisterone and combined 18-metayl-norethisterone on lipid metabolism in healthy women].
Li Y; Dong G; Wu Y
Zhonghua Fu Chan Ke Za Zhi; 2000 Nov; 35(11):680-3. PubMed ID: 11218899
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral contraceptives on protein metabolism.
Amatayakul K; Laokuldilok T; Koottathep S; Dejsarai W; Prapamontol T; Srirak N; Tansuhaj A; Uttaravichai C
J Med Assoc Thai; 1994 Oct; 77(10):509-16. PubMed ID: 7745371
[TBL] [Abstract][Full Text] [Related]
12. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
Barditch-Crovo P; Trapnell CB; Ette E; Zacur HA; Coresh J; Rocco LE; Hendrix CW; Flexner C
Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
[TBL] [Abstract][Full Text] [Related]
13. Triphasic pills: variability of endocrine parameters and of sex steroid-binding globulins.
Pasinetti E; Falsetti L
Acta Eur Fertil; 1993; 24(2):67-70. PubMed ID: 8171924
[TBL] [Abstract][Full Text] [Related]
14. Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity.
Corradini SG; Eramo A; Lubrano C; Spera G; Cornoldi A; Grossi A; Liguori F; Siciliano M; Pisanelli MC; Salen G; Batta AK; Attili AF; Badiali M
Obes Surg; 2005 Mar; 15(3):367-77. PubMed ID: 15826472
[TBL] [Abstract][Full Text] [Related]
15. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
[TBL] [Abstract][Full Text] [Related]
17. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
[TBL] [Abstract][Full Text] [Related]
18. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
Palatsi R; Hirvensalo E; Liukko P; Malmiharju T; Mattila L; Riihiluoma P; Ylöstalo P
Acta Derm Venereol; 1984; 64(6):517-23. PubMed ID: 6084924
[TBL] [Abstract][Full Text] [Related]
19. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
20. Contraception with subdermal implants releasing levonorgestrel. A clinical and pharmacological study.
Olsson SE
Acta Obstet Gynecol Scand Suppl; 1987; 142():1-45. PubMed ID: 3116821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
